Helixmith Co (XKRX:084990) Total Liabilities : ₩6,852 Mil (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Helixmith Co Total Liabilities?

Helixmith Co's Total Liabilities for the quarter that ended in Dec. 2024 was ₩6,852 Mil.

Helixmith Co's quarterly Total Liabilities declined from Jun. 2024 (₩6,266.24 Mil) to Sep. 2024 (₩6,075.50 Mil) but then increased from Sep. 2024 (₩6,075.50 Mil) to Dec. 2024 (₩6,851.97 Mil).

Helixmith Co's annual Total Liabilities increased from Dec. 2022 (₩37,583.55 Mil) to Dec. 2023 (₩73,557.54 Mil) but then declined from Dec. 2023 (₩73,557.54 Mil) to Dec. 2024 (₩6,851.97 Mil).

Helixmith Co Total Liabilities Historical Data

The historical data trend for Helixmith Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helixmith Co Total Liabilities Chart

Helixmith Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

197,780.49

57,368.41

37,583.55

73,557.54

6,851.97

Helixmith Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															73,557.54	53,295.99	6,266.24	6,075.50	6,851.97

Helixmith Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Helixmith Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6435.333	+	(192.575	+	-0.00099999999986267
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	224.065	+	0)
	=	6,852

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	148889.639	-	142037.667
	=	6,852

Helixmith Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6435.333	+	(192.575	+	-0.00099999999986267
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	224.065	+	0)
	=	6,852

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	148889.639	-	142037.667
	=	6,852

Helixmith Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Helixmith Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Helixmith Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helixmith Co Ltd (XKRX:084990) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Gwanak-ro, Gwanak-gu, 5th Floor, Building Number 203, Seoul National University, Seoul, KOR, 08826

Website

https://www.helixmith.com

Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.

Helixmith Co Headlines

No Headlines